- The management of post-transplantation recurrence of hepatocellular carcinoma
-
Rajendran L, Ivanics T, Claasen MP, Muaddi H, Sapisochin G
- KMID: 2523866
- Clin Mol Hepatol.
- 2022 Jan;28(1):1-16.
- doi: 10.3350/cmh.2021.0217
The annual incidence of hepatocellular carcinoma (HCC) continues to rise. Over the last two decades, liver transplantation (LT) has become the preferable treatment of HCC, when feasible and strict selection... -
- CITED
-
- Close
- SHARE
-
- Close
- Preoperative neutrophil-to-lymphocyte ratio is prognostic for early recurrence after curative intrahepatic cholangiocarcinoma resection
-
Choi WJ, Perez FM, Gravely A, Ivanics T, Claasen MPAW, Abraham L, Abreu P, Visser R, Gallinger S, Hansen BE, Sapisochin G
- KMID: 2542579
- Ann Hepatobiliary Pancreat Surg.
- 2023 May;27(2):158-165.
- doi: 10.14701/ahbps.22-114
Backgrounds/Aims: Within two years of surgery, 70% of resected intrahepatic cholangiocarcinoma (iCCA) recur. Better biomarkers are needed to identify those at risk of “early recurrence” (ER). In this study, we... -
- CITED
-
- Close
- SHARE
-
- Close
